(Q39856837)

15 September 2017

title

Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis (English)

1 reference

15 September 2017

Tomohiko Yoshida

1

1 reference

15 September 2017

Ayanna Flegler

series ordinal

2

1 reference

15 September 2017

Andrew Kozlov

series ordinal

3

1 reference

15 September 2017

Paula H Stern

series ordinal

4

1 reference

15 September 2017

publication date

1 August 2009

1 reference

Journal of Cellular Biochemistry

15 September 2017

published in

1 reference

15 September 2017

volume

107

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

917-925

1 reference

Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation

15 September 2017

cites work

1 reference

Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway

21 January 2018

1 reference

Advanced glycation of beta 2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosis

21 January 2018

1 reference

Possible involvement of advanced glycation end-products in bone resorption

21 January 2018

1 reference

Advanced glycation end products and receptor for advanced glycation end products in AA amyloidosis

21 January 2018

1 reference

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.22192

1 reference

release_jt5o73tqlzc5lefjot3hvs2g6a

15 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jt5o73tqlzc5lefjot3hvs2g6a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference